Founded by UC Berkeley scientists, GenEdit is a genome editing company that is developing delivery technologies for CRISPR/Cas9 based therapeutics.


At GenEdit, we’re focused on developing CRISPR based therapeutics that will change our world.



Professor George Church, Harvard

Scientific advisory board

Mattew Rabinowitz, CEO of Natera

Advisory board

Stephanie Marrus, Director of UCSF Entrepreneurship center

Advisory board  



Kunwoo Lee, Ph.D.

CEO and Co-founder

Hyo Min Park, Ph.D.

CTO and Co-founder

Professor Niren Murthy, UC Berkeley

Co-founder and scientific advisor